node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
AKR1C5 | CBR1 | ENSOCUP00000017578 | ENSOCUP00000016888 | Prostaglandin-E(2) 9-reductase; Can convert prostaglandin E2 to prostaglandin F2-alpha. | Carbonyl reductase [NADPH] 1; NADPH-dependent reductase with broad substrate specificity. Catalyzes the reduction of a wide variety of carbonyl compounds including quinones, prostaglandins, menadione, plus various xenobiotics. Catalyzes the reduction of the antitumor anthracyclines doxorubicin and daunorubicin to the cardiotoxic compounds doxorubicinol and daunorubicinol. Can convert prostaglandin E2 to prostaglandin F2- alpha. Can bind glutathione, which explains its higher affinity for glutathione-conjugated substrates. Catalyzes the reduction of S- nitrosoglutathione (By similarity). | 0.623 |
AKR1C5 | G1TLJ2_RABIT | ENSOCUP00000017578 | ENSOCUP00000017843 | Prostaglandin-E(2) 9-reductase; Can convert prostaglandin E2 to prostaglandin F2-alpha. | Uncharacterized protein; Belongs to the short-chain dehydrogenases/reductases (SDR) family. | 0.552 |
AKR1C5 | G1U2X0_RABIT | ENSOCUP00000017578 | ENSOCUP00000023724 | Prostaglandin-E(2) 9-reductase; Can convert prostaglandin E2 to prostaglandin F2-alpha. | Uncharacterized protein; Belongs to the short-chain dehydrogenases/reductases (SDR) family. | 0.552 |
AKR1C5 | GCLC | ENSOCUP00000017578 | ENSOCUP00000044485 | Prostaglandin-E(2) 9-reductase; Can convert prostaglandin E2 to prostaglandin F2-alpha. | Glutamate-cysteine ligase catalytic subunit. | 0.813 |
AKR1C5 | GCLM | ENSOCUP00000017578 | ENSOCUP00000011864 | Prostaglandin-E(2) 9-reductase; Can convert prostaglandin E2 to prostaglandin F2-alpha. | Glutamate-cysteine ligase modifier subunit. | 0.545 |
AKR1C5 | KCNAB3 | ENSOCUP00000017578 | ENSOCUP00000040526 | Prostaglandin-E(2) 9-reductase; Can convert prostaglandin E2 to prostaglandin F2-alpha. | Potassium voltage-gated channel subfamily A regulatory beta subunit 3. | 0.514 |
AKR1C5 | LOC100348029 | ENSOCUP00000017578 | ENSOCUP00000018584 | Prostaglandin-E(2) 9-reductase; Can convert prostaglandin E2 to prostaglandin F2-alpha. | Uncharacterized protein; Belongs to the short-chain dehydrogenases/reductases (SDR) family. | 0.552 |
AKR1C5 | NQO1 | ENSOCUP00000017578 | ENSOCUP00000026851 | Prostaglandin-E(2) 9-reductase; Can convert prostaglandin E2 to prostaglandin F2-alpha. | NAD(P)H quinone dehydrogenase 1. | 0.572 |
AKR1C5 | PTGR1 | ENSOCUP00000017578 | ENSOCUP00000044316 | Prostaglandin-E(2) 9-reductase; Can convert prostaglandin E2 to prostaglandin F2-alpha. | Prostaglandin reductase 1; Functions as 15-oxo-prostaglandin 13-reductase and acts on 15-oxo-PGE1, 15-oxo-PGE2 and 15-oxo-PGE2-alpha. Has no activity towards PGE1, PGE2 and PGE2-alpha. Catalyzes the conversion of leukotriene B4 into its biologically less active metabolite, 12-oxo-leukotriene B4. This is an initial and key step of metabolic inactivation of leukotriene B4 (By similarity). | 0.656 |
AKR1C5 | TMEM150B | ENSOCUP00000017578 | ENSOCUP00000010985 | Prostaglandin-E(2) 9-reductase; Can convert prostaglandin E2 to prostaglandin F2-alpha. | Transmembrane protein 150B. | 0.529 |
CBR1 | AKR1C5 | ENSOCUP00000016888 | ENSOCUP00000017578 | Carbonyl reductase [NADPH] 1; NADPH-dependent reductase with broad substrate specificity. Catalyzes the reduction of a wide variety of carbonyl compounds including quinones, prostaglandins, menadione, plus various xenobiotics. Catalyzes the reduction of the antitumor anthracyclines doxorubicin and daunorubicin to the cardiotoxic compounds doxorubicinol and daunorubicinol. Can convert prostaglandin E2 to prostaglandin F2- alpha. Can bind glutathione, which explains its higher affinity for glutathione-conjugated substrates. Catalyzes the reduction of S- nitrosoglutathione (By similarity). | Prostaglandin-E(2) 9-reductase; Can convert prostaglandin E2 to prostaglandin F2-alpha. | 0.623 |
CBR1 | G1TLJ2_RABIT | ENSOCUP00000016888 | ENSOCUP00000017843 | Carbonyl reductase [NADPH] 1; NADPH-dependent reductase with broad substrate specificity. Catalyzes the reduction of a wide variety of carbonyl compounds including quinones, prostaglandins, menadione, plus various xenobiotics. Catalyzes the reduction of the antitumor anthracyclines doxorubicin and daunorubicin to the cardiotoxic compounds doxorubicinol and daunorubicinol. Can convert prostaglandin E2 to prostaglandin F2- alpha. Can bind glutathione, which explains its higher affinity for glutathione-conjugated substrates. Catalyzes the reduction of S- nitrosoglutathione (By similarity). | Uncharacterized protein; Belongs to the short-chain dehydrogenases/reductases (SDR) family. | 0.900 |
CBR1 | G1U2X0_RABIT | ENSOCUP00000016888 | ENSOCUP00000023724 | Carbonyl reductase [NADPH] 1; NADPH-dependent reductase with broad substrate specificity. Catalyzes the reduction of a wide variety of carbonyl compounds including quinones, prostaglandins, menadione, plus various xenobiotics. Catalyzes the reduction of the antitumor anthracyclines doxorubicin and daunorubicin to the cardiotoxic compounds doxorubicinol and daunorubicinol. Can convert prostaglandin E2 to prostaglandin F2- alpha. Can bind glutathione, which explains its higher affinity for glutathione-conjugated substrates. Catalyzes the reduction of S- nitrosoglutathione (By similarity). | Uncharacterized protein; Belongs to the short-chain dehydrogenases/reductases (SDR) family. | 0.900 |
CBR1 | LOC100348029 | ENSOCUP00000016888 | ENSOCUP00000018584 | Carbonyl reductase [NADPH] 1; NADPH-dependent reductase with broad substrate specificity. Catalyzes the reduction of a wide variety of carbonyl compounds including quinones, prostaglandins, menadione, plus various xenobiotics. Catalyzes the reduction of the antitumor anthracyclines doxorubicin and daunorubicin to the cardiotoxic compounds doxorubicinol and daunorubicinol. Can convert prostaglandin E2 to prostaglandin F2- alpha. Can bind glutathione, which explains its higher affinity for glutathione-conjugated substrates. Catalyzes the reduction of S- nitrosoglutathione (By similarity). | Uncharacterized protein; Belongs to the short-chain dehydrogenases/reductases (SDR) family. | 0.900 |
G1TLJ2_RABIT | AKR1C5 | ENSOCUP00000017843 | ENSOCUP00000017578 | Uncharacterized protein; Belongs to the short-chain dehydrogenases/reductases (SDR) family. | Prostaglandin-E(2) 9-reductase; Can convert prostaglandin E2 to prostaglandin F2-alpha. | 0.552 |
G1TLJ2_RABIT | CBR1 | ENSOCUP00000017843 | ENSOCUP00000016888 | Uncharacterized protein; Belongs to the short-chain dehydrogenases/reductases (SDR) family. | Carbonyl reductase [NADPH] 1; NADPH-dependent reductase with broad substrate specificity. Catalyzes the reduction of a wide variety of carbonyl compounds including quinones, prostaglandins, menadione, plus various xenobiotics. Catalyzes the reduction of the antitumor anthracyclines doxorubicin and daunorubicin to the cardiotoxic compounds doxorubicinol and daunorubicinol. Can convert prostaglandin E2 to prostaglandin F2- alpha. Can bind glutathione, which explains its higher affinity for glutathione-conjugated substrates. Catalyzes the reduction of S- nitrosoglutathione (By similarity). | 0.900 |
G1TLJ2_RABIT | G1U2X0_RABIT | ENSOCUP00000017843 | ENSOCUP00000023724 | Uncharacterized protein; Belongs to the short-chain dehydrogenases/reductases (SDR) family. | Uncharacterized protein; Belongs to the short-chain dehydrogenases/reductases (SDR) family. | 0.900 |
G1TLJ2_RABIT | LOC100348029 | ENSOCUP00000017843 | ENSOCUP00000018584 | Uncharacterized protein; Belongs to the short-chain dehydrogenases/reductases (SDR) family. | Uncharacterized protein; Belongs to the short-chain dehydrogenases/reductases (SDR) family. | 0.900 |
G1U2X0_RABIT | AKR1C5 | ENSOCUP00000023724 | ENSOCUP00000017578 | Uncharacterized protein; Belongs to the short-chain dehydrogenases/reductases (SDR) family. | Prostaglandin-E(2) 9-reductase; Can convert prostaglandin E2 to prostaglandin F2-alpha. | 0.552 |
G1U2X0_RABIT | CBR1 | ENSOCUP00000023724 | ENSOCUP00000016888 | Uncharacterized protein; Belongs to the short-chain dehydrogenases/reductases (SDR) family. | Carbonyl reductase [NADPH] 1; NADPH-dependent reductase with broad substrate specificity. Catalyzes the reduction of a wide variety of carbonyl compounds including quinones, prostaglandins, menadione, plus various xenobiotics. Catalyzes the reduction of the antitumor anthracyclines doxorubicin and daunorubicin to the cardiotoxic compounds doxorubicinol and daunorubicinol. Can convert prostaglandin E2 to prostaglandin F2- alpha. Can bind glutathione, which explains its higher affinity for glutathione-conjugated substrates. Catalyzes the reduction of S- nitrosoglutathione (By similarity). | 0.900 |